Accessibility Menu
Cardiovascular Sciences logo

Cardiovascular Sciences(OTC) CVSC

Market Cap$1.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2001)-100%
5 Year-50%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Cardiovascular Sciences last closing stock price
MetricPriceDate
Last closeUSD 0.002026-06-01
Cardiovascular Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-05-14
1 month+0%USD 0.002026-03-27
3 month+0%USD 0.002026-02-02
Year to date+0%USD 0.002025-10-31
1 year+0%USD 0.002025-05-19
3 year+0%USD 0.002023-05-17
5 year-50%USD 0.002021-05-18
Since inception-100%USD 10,000.002001-10-01

Cardiovascular Sciences Financials at a Glance

Market Cap

$1.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1259.52 (High)

Price

$0.00

Volume

4,379

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

CVSC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardiovascular Sciences

Cardiovascular Sciences, Inc. is an innovative technology enterprise focused on advancing healthcare through specialized medical products. The company offers a diverse portfolio of solutions aimed at addressing critical cardiovascular and surgical needs.

Products and Services
  • Anti Adhesion Technology to minimize post-surgical scarring
  • Proprietary Pyruvate Therapy for cardiac trauma treatment
  • Thromboresistant Coating to inhibit blood clot formation
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increasing demand for advanced cardiovascular solutions supports long-term potential
  • Innovative product development may enhance competitive positioning
Financial Highlights
  • Market capitalization stands at approximately $1,696
  • Stock price has fluctuated between $0.000001 and $0.0001
  • Recent trading volume indicates growing investor interest
Cardiovascular Sciences, Inc. is dedicated to addressing significant healthcare challenges through its advanced medical technologies. The company's focus on innovative solutions positions it well within the personal products and services industry. With a commitment to research and development, Cardiovascular Sciences aims to enhance patient outcomes and improve surgical procedures. The growth outlook suggests potential for expansion and increased market share, driven by the rising demand for specialized cardiovascular products. Financial highlights indicate a stable market presence, with recent trading activity reflecting investor interest in the company's future prospects.
AI Generated • Jul 17, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

Heathrow, US

CVSC Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$1.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

16.96M

Volume

4.38K

Avg. Volume

70.302

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Cardiovascular Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$1.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BONTQThe Bon-Ton Stores, Inc.
$0.00+0.00%
PLNTQProliance International, Inc.
$0.00+0.00%
ARVLFArrival
$0.00+0.00%
SIMPQSimply Inc
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$108.27-0.14%
NVDANvidia
$219.22+0.03%
ONDSOndas
$8.87+0.00%
PATHUiPath
$13.82-0.02%

Questions About CVSC

What is the current price of Cardiovascular Sciences?

Cardiovascular Sciences is trading at $0.00 per share.

What is the 52-week range for Cardiovascular Sciences?

Over the past 52 weeks, Cardiovascular Sciences has traded between $0.00 and $0.00.

How much debt does Cardiovascular Sciences have?

Cardiovascular Sciences total debt is unavailable.

How much cash does Cardiovascular Sciences have on hand?

Cardiovascular Sciences does not have cash on hand data available.

What is Cardiovascular Sciences’s dividend yield?

Cardiovascular Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services